- /
- Supported exchanges
- / US
- / LNSR.NASDAQ
LENSAR Inc (LNSR NASDAQ) stock market data APIs
LENSAR Inc Financial Data Overview
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LENSAR Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LENSAR Inc data using free add-ons & libraries
Get LENSAR Inc Fundamental Data
LENSAR Inc Fundamental data includes:
- Net Revenue: 58 435 K
- EBITDA: -20 076 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LENSAR Inc News
New
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The updated analyst narrative around LENSAR now centers o...
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management�...
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The reset in LENSAR’s fair value price target from $12.50...
LENSAR, Inc. Q4 2025 Earnings Call Summary
LENSAR, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Pivot and Operational Recovery Management attributes the termination of the Alcon merger to the Federal Trade Commission's intent to enjoi...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.